Trade Summary

3 days ago, Smith Hunter C, serving as Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 62,774 shares at $105.46 per share, for a total transaction value of $6,619,913.40. Following this transaction, Smith Hunter C now holds 114,024 shares of RYTM.

This sale represents a 35.51% decrease in Smith Hunter C's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 31, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 1, 2026 at 4:22 PM ET, 1 day after the trade was made.

RHYTHM PHARMACEUTICALS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.